Abstract:Abstract The identification of interactions between drugs/compounds and their targets is crucial for the development of new drugs. In vitro screening experiments (i.e. bioassays) are frequently used for this purpose; however, experimental approaches are insufficient to explore novel drug-target interactions, mainly because of feasibility problems, as they are labour intensive, costly and time consuming. A computational field known as ‘virtual screening’ (VS) has emerged in the past decades to aid experimental drug discovery studies by statistically estimating unknown bio-interactions between compounds and biological targets. These methods use the physico-chemical and structural properties of compounds and/or target proteins along with the experimentally verified bio-interaction information to generate predictive models. Lately, sophisticated machine learning techniques are applied in VS to elevate the predictive performance. The objective of this study is to examine and discuss the recent applications of machine learning techniques in VS, including deep learning, which became highly popular after giving rise to epochal developments in the fields of computer vision and natural language processing. The past 3 years have witnessed an unprecedented amount of research studies considering the application of deep learning in biomedicine, including computational drug discovery. In this review, we first describe the main instruments of VS methods, including compound and protein features (i.e. representations and descriptors), frequently used libraries and toolkits for VS, bioactivity databases and gold-standard data sets for system training and benchmarking. We subsequently review recent VS studies with a strong emphasis on deep learning applications. Finally, we discuss the present state of the field, including the current challenges and suggest future directions. We believe that this survey will provide insight to the researchers working in the field of computational drug discovery in terms of comprehending and developing novel bio-prediction methods.

Recent Progresses in the Exploration of Machine Learning Methods As In-Silico ADME Prediction Tools

Advances In Machine Learning Prediction Of Toxicological Properties And Adverse Drug Reactions Of Pharmaceutical Agents

Predicting ADME properties in silico: methods and models

Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery

Recent Advances On In Silico Adme Modeling

Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.

In silico ADME-Tox modeling: progress and prospects

Open access in silico tools to predict the ADMET profiling of drug candidates

A review on machine learning methods for in silico toxicity prediction

The Application of in Silico Drug-Likeness Predictions in Pharmaceutical Research.

In Silico Prediction Of Adverse Drug Reactions And Toxicities Based On Structural, Biological And Clinical Data

Recent advances in computational prediction of drug absorption and permeability in drug discovery.

Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties

Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

Machine Learning Small Molecule Properties in Drug Discovery

A compact review of progress and prospects of deep learning in drug discovery

Perspectives on the use of machine learning for ADME prediction at AstraZeneca

Interpretable-ADMET: a web service for ADMET prediction and optimization based on deep neural representation

The recent progress of deep-learning-based in silico prediction of drug combination